DARPA‘s ElectRx research program aims to develop high precision, minimally-invasive neuromodulation technologies to treat diseases including rheumatoid arthritis, epilepsy and PTSD.
Implanted ultraminiaturized devices would modulate the peripheral nervous system’s response to infections, injuries or other imbalances.
Project manager Doug Weber claims that ElectRX technologies “would continually assess conditions and provide stimulus patterns tailored to help maintain healthy organ function, helping patients get healthy and stay healthy using their body’s own systems.”